Aashka Hospitals Ltd Stock Price Today (NSE: AASHKA)
Fundamental Score
Aashka Hospitals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Aashka Hospitals Ltd share price today is ₹59.00, down 4.86% on NSE/BSE as of 30 March 2026. Aashka Hospitals Ltd (AASHKA) is a Small-cap company in the Hospital sector with a market capitalisation of ₹213.53 (Cr). The 52-week high for AASHKA share price is ₹107.75 and the 52-week low is ₹62.80. At a P/E ratio of 187.31x, AASHKA is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 2.39% and a debt-to-equity ratio of 0.13.
Aashka Hospitals Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Aashka Hospitals Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
A Conservative Value Investor's Perspective on Aashka Hospitals Share Price
The healthcare sector, while often considered recession-resistant, presents unique challenges for value investors. Intense regulatory scrutiny and the need for continuous capital expenditure for technological upgrades demand a cautious approach. This analysis examines the financial standing of Aashka Hospitals Ltd, specifically regarding its current share price of ₹79.9000015258789, from a capital safety perspective. The Aashka Hospitals share price reflects investor sentiment, which this analysis attempts to dissect objectively.
A crucial metric in our assessment is the Price-to-Earnings (PE) ratio of 187.31. This significantly elevated PE suggests that investors are anticipating substantial future earnings growth. However, as value investors, we prioritize tangible, current performance. A high PE warrants extreme caution, demanding a deeper examination of the underlying financials to justify such optimistic projections. The management quality, as evidenced by their capital allocation decisions and strategic foresight, should also be judged in comparison to peers. For example, analyzing
Nephro Care India Limited's management track record alongside Aashka's can provide valuable insights into comparative efficiency.The Return on Capital Employed (ROCE) of Aashka Hospitals, currently at 4.07%, raises concerns. ROCE is a vital indicator of how effectively a company utilizes its capital to generate profits. A low ROCE, especially when compared to the cost of capital, indicates potential challenges in wealth creation. The impact on the company's 'moat' – its competitive advantage – is considerable. A low ROCE suggests difficulty in generating above-average returns, making it harder to defend market share and attract future investment. In contrast, robust competitors with significantly higher ROCE figures enjoy a distinct advantage, potentially eroding Aashka's future prospects.
In conclusion, while the healthcare sector offers opportunities, a conservative approach requires a thorough understanding of valuation metrics and underlying fundamentals. A detailed 80-parameter fundamental audit, verified by Sweta Mishra, is essential before making any investment decisions. The current financial data of Aashka Hospitals, particularly the high PE and low ROCE, warrants considerable scrutiny from a value investing standpoint concerned with the preservation of capital. This analysis offers an observational view and does not constitute financial advice. We encourage independent research and consultation with qualified professionals.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Aashka Hospitals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AASHKA across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (19.07%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Conservative Debt Levels (D/E: 0.13)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (61.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (2.39%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.07%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 187.31x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-82.72%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-15.53%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-3.62% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (1.98x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-42.68 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Aashka Hospitals Ltd Financial Statements
Comprehensive financial data for Aashka Hospitals Ltd including income statement, balance sheet and cash flow
About AASHKA (Aashka Hospitals Ltd)
Aashka Hospitals Ltd is a beacon of advanced medical care, standing as a multi-specialty institution dedicated to healing and wellness. The hospital complex is a modern architectur...al marvel, designed to provide a serene and comforting environment for patients and their families. Within its walls, state-of-the-art technology seamlessly integrates with compassionate care, offering a holistic approach to treatment. From the welcoming reception area bathed in natural light to the meticulously designed patient rooms, every detail is curated to foster recovery and well-being. Aashka Hospitals strives to be more than just a healthcare provider; it aspires to be a trusted partner in every individual's journey to better health. Aashka Hospitals boasts a wide range of specialized departments, each staffed by leading experts in their respective fields. Patients can access a comprehensive suite of services, including advanced diagnostics, cutting-edge surgical procedures, and personalized treatment plans. The hospital is particularly renowned for its excellence in critical care, cardiac sciences, and neurological disorders, offering round-the-clock emergency services and specialized intensive care units. Beyond medical intervention, Aashka Hospitals emphasizes preventive care and health education, empowering individuals to take proactive steps towards maintaining their well-being. The institution believes in a collaborative approach, fostering open communication between patients, families, and healthcare professionals to ensure the best possible outcomes. Aashka Hospitals is committed to innovation and continuous improvement, constantly seeking new ways to enhance the quality and accessibility of healthcare. The hospital invests heavily in research and development, partnering with leading institutions to explore new treatments and technologies. Moreover, Aashka Hospitals is deeply rooted in the community, actively participating in outreach programs and initiatives aimed at promoting public health. With a strong emphasis on ethical practices and patient-centric care, Aashka Hospitals strives to set a new standard of excellence in the healthcare industry, providing hope and healing to all those who seek its services.
Company Details
Key Leadership
Latest News
AASHKA Share Price: Frequently Asked Questions
What is the current share price of Aashka Hospitals Ltd (AASHKA)?
As of 30 Mar 2026, 12:07 pm IST, Aashka Hospitals Ltd share price is ₹59.00. The AASHKA stock has a market capitalisation of ₹213.53 (Cr) on NSE/BSE.
Is AASHKA share price Overvalued or Undervalued?
AASHKA share price is currently trading at a P/E ratio of 187.31x, compared to the industry average of 52.84x. Based on this relative valuation, the Aashka Hospitals Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of AASHKA share price?
The 52-week high of AASHKA share price is ₹107.75 and the 52-week low is ₹62.80. These values are updated daily from NSE/BSE price data.
What factors affect the Aashka Hospitals Ltd share price?
Key factors influencing AASHKA share price include quarterly earnings growth (Sales Growth: -15.53%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Aashka Hospitals Ltd a good stock for long-term investment?
Aashka Hospitals Ltd shows a 5-year Profit Growth of 11.14% and an ROE of 2.39%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.13 before investing in AASHKA shares.
How does Aashka Hospitals Ltd compare with its industry peers?
Aashka Hospitals Ltd competes with major peers in the Hospital. Investors should compare AASHKA share price P/E of 187.31x and ROE of 2.39% against the industry averages to determine competitive standing.
What is the P/E ratio of AASHKA and what does it mean?
AASHKA share price has a P/E ratio of 187.31x compared to the industry average of 52.84x. Investors pay ₹187 for every ₹1 of annual earnings.
How is AASHKA performing according to Bull Run's analysis?
AASHKA has a Bull Run fundamental score of 20.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does AASHKA belong to?
AASHKA operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Aashka Hospitals Ltd share price.
What is Return on Equity (ROE) and why is it important for AASHKA?
AASHKA has an ROE of 2.39%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Aashka Hospitals Ltd generates profits from shareholders capital.
How is AASHKA debt-to-equity ratio and what does it indicate?
AASHKA has a debt-to-equity ratio of 0.13, which indicates conservative financing with low financial risk.
What is AASHKA dividend yield and is it a good dividend stock?
AASHKA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Aashka Hospitals Ltd shares.
How has AASHKA share price grown over the past 5 years?
AASHKA has achieved 5-year growth rates of: Sales Growth -3.62%, Profit Growth 11.14%, and EPS Growth 5.46%.
What is the promoter holding in AASHKA and why does it matter?
Promoters hold 61.33% of AASHKA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Aashka Hospitals Ltd.
What is AASHKA market capitalisation category?
AASHKA has a market capitalisation of ₹214 crores, placing it in the Small-cap category.
How volatile is AASHKA stock?
AASHKA has a beta of N/A. A beta > 1 suggests the Aashka Hospitals Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is AASHKA operating profit margin trend?
AASHKA has a 5-year average Operating Profit Margin (OPM) of 19.07%, indicating the company's operational efficiency.
How is AASHKA quarterly performance?
Recent quarterly performance shows Aashka Hospitals Ltd YoY Sales Growth of -15.53% and YoY Profit Growth of -82.72%.
What is the institutional holding pattern in AASHKA?
AASHKA has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Aashka Hospitals Ltd stock.